HY-15125-1mL
|
MedChemexpress LLC
|
(R)-(+)-Bay-K-8644 [CAS 98791-67-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-117917-10mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-117917-100mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-117917-25mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-117917-5mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-117917-50mg
|
MedChemexpress LLC
|
(Rac)-MGV354 [CAS 1852495-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-107591A-1mg
|
MedChemexpress LLC
|
(Rac)-PF-184 (hydrate)
|
|
COVID-19-immunoregulation
|
|
HY-107591A-5mg
|
MedChemexpress LLC
|
(Rac)-PF-184 (hydrate)
|
|
COVID-19-immunoregulation
|
|
HY-141411-10mg
|
MedChemexpress LLC
|
(Rac)-Zevaquenabant [CAS 1610420-28-4]
|
|
COVID-19-immunoregulation
|
|
HY-141411-25mg
|
MedChemexpress LLC
|
(Rac)-Zevaquenabant [CAS 1610420-28-4]
|
|
COVID-19-immunoregulation
|
|
HY-141411-5mg
|
MedChemexpress LLC
|
(Rac)-Zevaquenabant [CAS 1610420-28-4]
|
|
COVID-19-immunoregulation
|
|
HY-141411-1mL
|
MedChemexpress LLC
|
(Rac)-Zevaquenabant [CAS 1610420-28-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-15124-1mg
|
MedChemexpress LLC
|
(S)-(-)-Bay-K-8644 [CAS 98625-26-4]
|
|
COVID-19-immunoregulation
|
|
HY-15124-10mg
|
MedChemexpress LLC
|
(S)-(-)-Bay-K-8644 [CAS 98625-26-4]
|
|
COVID-19-immunoregulation
|
|
HY-15124-5mg
|
MedChemexpress LLC
|
(S)-(-)-Bay-K-8644 [CAS 98625-26-4]
|
|
COVID-19-immunoregulation
|
|
HY-15124-50mg
|
MedChemexpress LLC
|
(S)-(-)-Bay-K-8644 [CAS 98625-26-4]
|
|
COVID-19-immunoregulation
|
|
HY-15124-1mL
|
MedChemexpress LLC
|
(S)-(-)-Bay-K-8644 [CAS 98625-26-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B0392-10mg
|
MedChemexpress LLC
|
(S)-(+)-Rolipram [CAS 85416-73-5]
|
|
COVID-19-immunoregulation
|
|
HY-B0392-100mg
|
MedChemexpress LLC
|
(S)-(+)-Rolipram [CAS 85416-73-5]
|
|
COVID-19-immunoregulation
|
|
HY-B0392-5mg
|
MedChemexpress LLC
|
(S)-(+)-Rolipram [CAS 85416-73-5]
|
|
COVID-19-immunoregulation
|
|
HY-B0392-50mg
|
MedChemexpress LLC
|
(S)-(+)-Rolipram [CAS 85416-73-5]
|
|
COVID-19-immunoregulation
|
|
HY-B0392-1mL
|
MedChemexpress LLC
|
(S)-(+)-Rolipram [CAS 85416-73-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-108601A-1mg
|
MedChemexpress LLC
|
(S)-Ro 32-0432 [CAS 1781828-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-P1159A-10mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
HY-P1159A-5mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|